2016-2019年我国9城市门急诊脑卒中患者处方合理性分析

目的:通过回顾性研究我国9个城市脑卒中患者的处方数据,分析评价脑卒中患者门急诊处方用药合理性,以期为临床合理用药提供参考.方法:收集2016-2019年期间我国9个城市120家样本医疗卫生机构的抽样处方,对患者用药情况进行分析.结果:我国脑卒中患者发病年龄段集中在61～80岁,占比超过50％,男女比例为3∶2;就诊科室...

Rationality of prescriptions of stroke patients in outpatient and emergency departments at sample hospitals of nine domestic cities from 2016 to 2019

OBJECTIVE To perform a retrospective review of the prescriptions of stroke patients and preliminarily evaluate the current status of stroke medications to provide references for clinical rational medication use.METHODS Clinical data were collected from sample prescription of 120 healthcare institutions in 9 domestic cities and patient medication status was analyzed.RESULTS The stroke patients had an age range of 61-80 years accounting for over 50%; the ratio of male to female was around 3 to 2; top three clinical departments were neurology (47.0%), neurosurgery (9.6%) and senior cadre (7.8%); top 10 drugs in terms of prescription volume included lipid-regulators, antiplatelet drugs, neuroprotective agents, expectorants, electrolyte balance regulators and antihypertensives. Some problems persisted in rational usage or dosage of lipid-regulating drugs, antiplatelet drugs, expectorants and neuroprotective agents. For example, optimal dose of ambroxol remained uncertain and there was an abuse of neuroprotective agents. The economic burden of drug dosing decreased somewhat in stroke patients.CONCLUSION Stroke medication in China needs to be further standardized for boosting the safety, effectiveness and economy of patient medication.